Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11365233 Activatable cytokine constructs and related compositions and methods

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
CytomX Therapeutics
CytomX Therapeutics
Date Filed
April 9, 2021
Date of Patent
June 21, 2022
Patent Applicant
CytomX Therapeutics
CytomX Therapeutics
Patent Application Number
17227017
Patent Citations
‌
US Patent 10683368 Fc-region variants with modified FcRn-binding and methods of use
‌
US Patent 10696723 Activatable interleukin 12 polypeptides
‌
US Patent 10875913 Methods of treatment using activatable anti-EGFR antibodies
‌
US Patent 10696724 Activatable interleukin-2 polypeptides
‌
US Patent 11028162 Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties
‌
US Patent 10059762 Anti-EGFR activatable antibodies
‌
US Patent 10077300 Activatable binding polypeptides and methods of identification and use thereof
‌
US Patent 10118961 Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
‌
US Patent 10513549 Cleavage-activatable interferon-alpha proprotein
Patent Citations Received
‌
US Patent 11667687 Masked activatable interferon constructs
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11365233
Patent Primary Examiner
‌
Ruixiang Li
CPC Code
‌
C07K 14/56
‌
C07K 2319/02
‌
C07K 2319/30

Find more entities like US Patent 11365233 Activatable cytokine constructs and related compositions and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo